Clinical Trials in Salt Lake City

Showing 3021-3040 of 7,997 trials

A Brief Mind-Body Bridging Intervention for Suicidal Ideation

NCT03677882

The aim of this study is to determine whether a Brief Mind-Body Bridging Intervention for Suicidal Ideation (MBB-SI) will result in short or longer-term reduction of psychological factors associated with suicidal ideation (SI) and/or suicide-related behaviors (SRB's) compared to Treatment as Usual (TAU).

Suicidal IdeationMind Body Bridging

VA Salt Lake City Health Care System13 participantsStarted Dec 2018

Salt Lake City, Utah, United States

TERMINATEDPhase 3< 1 mile

PF-07304814 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)

NCT05780541

This study looks at the safety and effectiveness of PF-07304814 in treating COVID-19 in people who have been hospitalized with the infection. Participants in the study will be treated with either PF-07304814 plus current standard of care (SOC), or with placebo plus current SOC. This is ACTIV-3/TICO Treatment Trial H6.

COVID-19

National Institute of Allergy and Infectious Diseases (NIAID)58 participantsStarted Sep 2021

Chula Vista, California, United States • Los Angeles, California, United States • Mather, California, United States +37 more locations

A Brief Mind-Body Bridging Intervention for Suicidal Ideation

PF-07304814 for Inpatients With COVID-19 (An ACTIV-3/TICO Treatment Trial)

Find Trials by Condition in Salt Lake City

Phase III Double-blind, Placebo-controlled Study of AZD1222 for the Prevention of COVID-19 in Adults

Long-term Safety and Efficacy of GSK3196165 (Otilimab) in the Treatment of Rheumatoid Arthritis (RA)

ILLUMENATE Pivotal Post-Approval Study (PAS)

Development of a Cell Free DNA Assay as a Biomarker for Predicting Early Non-response to Therapy in Metastatic Cancer

Study in Pediatric Subjects With Peanut Allergy to Evaluate Efficacy and Safety of Dupilumab as Adjunct to AR101 (Peanut Oral Immunotherapy)

A Prospective, Global, Multi-center, Treatment Registry Study of Intravenous Immunoglobulin Maintenance Therapy in Alloantibody Positive Renal Allograft Recipients

A Study of H3B-8800 (RVT-2001) in Participants With Lower Risk Myelodysplastic Syndromes

A Study of AL101 Monotherapy in Patients With Notch Activated Triple Negative Breast Cancer

Pleconaril Enteroviral Sepsis Syndrome

A Phase 2 Study to Evaluate the Safety and Efficacy of ABP-450 in the Treatment of Cervical Dystonia

A Study to Assess the Pharmacokinetics of Certolizumab Pegol in Adults With Active Rheumatoid Arthritis

Study of Mucosal Sparing Adjuvant Radiotherapy After Surgical Exploration in HPV+ Head and Neck Cancer of Unknown Primaries

OSE2101 Versus Chemotherapy in HLA-A2 Positive Patients With Advanced NSCLC After Immune Checkpoint Inhibitor Failure

Study of XL184 (Cabozantinib) in Adults With Glioblastoma Multiforme

A Study of LY3471851 in Participants With Psoriasis

A Study Of Safety, Tolerability And Effectiveness Of Recifercept In Children With Achondroplasia

DS-6157a in Participants With Advanced Gastrointestinal Stromal Tumor (GIST)

A Long-Term Safety Trial of LUM-201 in Children With Idiopathic Growth Hormone Deficiency Who Have Previously Completed a LUM-201 Clinical Trial (OraGrowtH211)